108 studies found for:    Open Studies | "Nasopharyngeal Neoplasms"
Show Display Options
Rank Status Study
1 Not yet recruiting Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Conditions: Nasopharyngeal Neoplasms;   Stomatitis
Interventions: Drug: Oral Ulcer Gargle (FORRAD®);   Drug: Quadruple mixture, composed of dexamethasone, gentamicin, vitamin B12, and procaine
2 Not yet recruiting Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Conditions: Nasopharyngeal Neoplasms;   Radiodermatitis
Interventions: Drug: Medical Radiation Protectants (FORRAD®);   Drug: Trolamine (Biafine)
3 Recruiting Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Radiation: IMRT using individualized CTV;   Radiation: IMRT using traditional CTV;   Drug: Gemcitabine and cisplatin (induction chemotherapy);   Drug: Docetaxel and cisplatin (induction chemotherapy);   Drug: Cisplatin 100mg/m² concurrent chemotherapy;   Drug: Cisplatin 80mg/m² concurrent chemotherapy
4 Recruiting Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122)
Condition: Nasopharyngeal Neoplasms
Interventions: Biological: pembrolizumab;   Drug: capecitabine;   Drug: gemcitabine;   Drug: docetaxel
5 Not yet recruiting Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.
Conditions: Nasopharyngeal Neoplasms;   Mortality;   Quality of Life;   Complications
Interventions: Radiation: Hyperfractionated IMRT;   Radiation: Conventional Fraction IMRT
6 Recruiting Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Paclitaxel;   Drug: Bevacizumab;   Drug: Carboplatin
7 Recruiting Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Neoplasms;   Blood Cell Count;   Neoplasm Staging;   Prognosis
Intervention:
8 Recruiting A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Conditions: Nasopharyngeal Neoplasms;   Salivary Gland Diseases;   Bone Marrow Diseases;   Mucositis
Interventions: Drug: Amifostine every-other-day regimen;   Drug: Amifostine everyday regimen
9 Recruiting Environmental and Genetic Determinants of NPC
Conditions: Nasopharyngeal Neoplasms;   Herpesvirus 4, Human
Intervention:
10 Unknown  Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
Condition: Nasopharyngeal Neoplasms
Interventions: Procedure: Conventional Radiotherapy;   Procedure: Accelerated Radiotherapy;   Drug: Cisplatin;   Drug: 5-fluorouracil;   Drug: Capecitabine
11 Unknown  Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Oxaliplatin
12 Not yet recruiting The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma
Condition: Effects of Chemotherapy
Interventions: Drug: Concurrent chemotherapy with cisplatin;   Radiation: Intensity modulated radiotherapy
13 Not yet recruiting Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Valproic acid;   Drug: Valganciclovir
14 Recruiting A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)
Condition: Cancer
Intervention: Drug: ARGX-110
15 Recruiting Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program
Conditions: Attenuated Familial Adenomatous Polyposis;   Deleterious Familial Adenomatous Polyposis
Intervention: Other: Chart Review
16 Not yet recruiting Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Donafenib
17 Recruiting Individualized Elective Neck Irradiation Based on MRI in NPC Patients
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Elective neck irradiation;   Radiation: Whole neck irradiation
18 Recruiting Endostar for Locally Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Endostatins;   Radiation: IMRT
19 Recruiting Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: IMRT;   Drug: Cisplatin
20 Recruiting Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cetuximab;   Drug: Cisplatin;   Drug: Docetaxel;   Drug: Capecitabine;   Radiation: Radiotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years